awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q55429844-0B653917-4934-4701-94A3-3373F617D9F4
Q55429844-0B653917-4934-4701-94A3-3373F617D9F4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q55429844-0B653917-4934-4701-94A3-3373F617D9F4
Omalizumab in Chronic Spontaneous Urticaria Refractory to Conventional Therapy: An Italian Retrospective Clinical Analysis with Suggestions for Long-Term Maintenance Strategies.
P2860
Q55429844-0B653917-4934-4701-94A3-3373F617D9F4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q55429844-0B653917-4934-4701-94A3-3373F617D9F4
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
f4495b49004ebd2816f77410e60e0c407c516cb3
P2860
Long-term efficacy of omalizumab in seven patients with treatment-resistant chronic spontaneous urticaria.